Search Results - "Segurado, Oscar G."

Novel therapies for graft versus host disease with a focus on cell therapies by Zeiser, Robert, Ringden, Olle, Sadeghi, Behnam, Gonen-Yaacovi, Gil, Segurado, Oscar G.

“…Graft versus host disease (GVHD) can occur at any period post allogeneic hematopoietic stem cell transplantation as a common clinical complication contributing…”
Get full text

Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials by PINCUS, Theodore, AMARA, Ingrid, SEGURADO, Oscar G, BERGMAN, Martin, KOCH, Gary G

“…OBJECTIVE: To estimate relative efficiencies of the 7 rheumatoid arthritis (RA) Core Data Set measures to distinguish adalimumab from control treatments in 4…”
Get full text

An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis by PINCUS, Theodore, CHUNG, Cecilia, SEGURADO, Oscar G, AMARA, Ingrid, KOCH, Gary G

“…OBJECTIVE: To analyze 2 indices composed of the 3 patient reported outcomes (PRO) in the American College of Rheumatology (ACR) Core Data Set--physical…”
Get full text

Cost-Effectiveness of Sequential Therapy with Tumor Necrosis Factor Antagonists in Early Rheumatoid Arthritis by DAVIES, Andrew, CIFALDI, Mary A, SEGURADO, Oscar G, WEISMAN, Michael H

“…Objective To estimate the comparative lifetime cost-effectiveness of sequenced therapy with tumor necrosis factor (TNF) antagonists as the initial therapeutic…”
Get full text

Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis by Fleischmann, Roy, Liu, Jingyu, Zhu, Julie, Segurado, Oscar G., Furst, Daniel E.

“…Objective Responsive assessment of disease activity in patients who have rheumatoid arthritis (RA) is necessary to evaluate therapeutic efficacy and guide…”
Get full text

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia by Lee, Yvonne C, Hackett, James, Frits, Michelle, Iannaccone, Christine K, Shadick, Nancy A, Weinblatt, Michael E, Segurado, Oscar G, Sasso, Eric H

“…To examine the association between a multibiomarker disease activity (MBDA) score, CRP and clinical disease activity measures among RA patients with and…”
Get full text

Clinical Assessment of Pain, Tolerability, and Preference of an Autoinjection Pen Versus a Prefilled Syringe for Patient Self-Administration of the Fully Human, Monoclonal Antibody Adalimumab: The TOUCH Trial by Kivitz, Alan, Cohen, Steven, Dowd, James Edward, Edwards, William, Thakker, Suman, Wellborne, Frank R., Renz, Cheryl L., Segurado, Oscar G.

“…Adalimumab is a therapeutic monoclonal antibody for SC administration by 2 single-use injection devices providing bioequivalent amounts of adalimumab: a…”
Get full text

Brief Report: Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi‐Biomarker Disease Activity Score as an Inclusion Criterion by van Vollenhoven, Ronald F., Bolce, Rebecca, Hambardzumyan, Karen, Saevarsdottir, Saedis, Forslind, Kristina, Petersson, Ingemar F., Sasso, Eric H., Hwang, C. C., Segurado, Oscar G., Geborek, Pierre

“…Objective Rheumatoid arthritis (RA) clinical trials often exclude patients who have low C‐reactive protein (CRP) levels, which slows enrollment into the trial…”
Get full text

HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab by Kivitz, Alan, Segurado, Oscar G

“…The HUMIRA (adalimumab) Pen is a novel, integrated, disposable autoinjection delivery system for the subcutaneous injection of adalimumab. Adalimumab is a…”
Get more information

Running out of steam by Segurado, Oscar G

“…In a ten-year period, Spain more than doubled the percentage of GNP it allocates to research, but that level is still one of the lowest in Europe. Spain's poor…”
Get full text

Enhancement of Patient Recruitment in Rheumatoid Arthritis Clinical Trials Using a Multi-Biomarker Disease Activity Score as an Inclusion Criterion by van, Vollenhoven RF, Bolce, R, Hambardzumyan, K, Saevarsdottir, S, Forslind, K, Petersson, IF, Sasso, EH, Hwang, CC, Segurado, OG, Geborek, P

Get full text

Spanish laboratory backs off bid to cut research staff by Segurado, Oscar G

Get full text

Spain expands despite financial and logistical hurdles by Segurado, Oscar G

“…Spain is hoping to expand its research facilities in spite of its lack of funds. The country plans to open new institutes for plant biology and food technology…”
Get full text

Genome ethics treaty by SEGURADO, OSCAR G, SCHENDEL, DOLORES J

Get full text

Restricted TCR repertoire and disease by Segurado, O G, Schendel, D J

Get more information

Expression and function of a variant T cell receptor complex lacking CD3-γ by PEREZ-ACIEGO, P, ALARCON, B, ARNAIZ-VILLENA, A, TERHORST, C, TIMON, M, SEGURADO, O. G, REGUEIRO, J. R

“…A T cell line termed DIL2 has been derived from an infant with a polyclonal T cell receptor (TCR)/CD3 cell surface expression defect. Indirect…”
Get full text

PSA standardization: a review of NCCLS, Stanford and Abbott efforts by Segurado, O G, Volmer, W, Dowell, B

“…The wide variances between prostate specific antigen (PSA) values for various assays and the demonstration that many of these differences are due to…”
Get more information

Identification of predominant T-cell receptor rearrangements by temperature-gradient gel electrophoresis and automated DNA sequencing by Segurado, O G, Schendel, D J

“…To assess the diversity of T-cell receptor (TCR) gene rearrangements in uncloned lymphocytes we used a three-stage strategy that allows the detection of a…”
Get more information

Two BF F subtypes, but no BF S, BF F1 or BF S07 subdivision, are found by isoelectric focusing by Segurado, O G, Arnaiz-Villena, A

“…When studied by immunoelectrophoresis the factor B (BF)*F allele is a monomorphic protein, but by using isoelectric focusing (IEF), it turns out to be…”
Get more information

Acquired selective signature dysgraphia by Regueiro, A M, Segurado, O G, Mata, P, Regueiro, J R

Get more information